Therapeutic Advances in Cardiovascular Disease

Scope & Guideline

Leading the Charge in Cardiovascular Therapeutics

Introduction

Immerse yourself in the scholarly insights of Therapeutic Advances in Cardiovascular Disease with our comprehensive guidelines detailing its aims and scope. This page is your resource for understanding the journal's thematic priorities. Stay abreast of trending topics currently drawing significant attention and explore declining topics for a full picture of evolving interests. Our selection of highly cited topics and recent high-impact papers is curated within these guidelines to enhance your research impact.
LanguageEnglish
ISSN1753-9447
PublisherSAGE PUBLICATIONS LTD
Support Open AccessYes
CountryUnited Kingdom
TypeJournal
Convergefrom 2007 to 2024
AbbreviationTHER ADV CARDIO DIS / Ther. Adv. Cardiovasc. Dis.
Frequency1 issue/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND

Aims and Scopes

The journal 'Therapeutic Advances in Cardiovascular Disease' focuses on advancing the understanding and treatment of cardiovascular diseases through innovative research and clinical studies. Its scope encompasses a wide range of topics within cardiovascular medicine, emphasizing both therapeutic interventions and the underlying mechanisms of cardiovascular pathologies.
  1. Cardiovascular Interventions:
    Research focused on various interventional techniques, including catheter-based therapies, surgical procedures, and novel technologies aimed at improving patient outcomes in cardiovascular disease.
  2. Pharmacotherapy and Drug Development:
    Exploration of pharmacological treatments for cardiovascular conditions, including studies on the efficacy, safety, and novel uses of existing medications as well as the development of new therapeutic agents.
  3. Pathophysiology and Mechanistic Studies:
    Investigations into the underlying biological mechanisms of cardiovascular diseases, including genetic, molecular, and cellular aspects that contribute to disease progression and treatment responses.
  4. Epidemiology and Public Health:
    Studies assessing the prevalence, risk factors, and outcomes of cardiovascular diseases across different populations, providing insights into health disparities and public health initiatives.
  5. Clinical Outcomes and Quality of Life:
    Research aimed at understanding the impact of cardiovascular diseases on patients' quality of life, including studies on outcomes following treatments and interventions.
Recent publications in 'Therapeutic Advances in Cardiovascular Disease' indicate a shift towards exploring innovative therapeutic strategies and the integration of personalized medicine in cardiovascular care. The following themes have emerged as particularly relevant and are gaining traction in the field.
  1. Genomics and Personalized Medicine:
    An increasing focus on genetic factors influencing cardiovascular disease and treatment responses, including studies on gene polymorphisms and microRNA interactions, highlights the trend towards personalized medicine.
  2. Impact of Lifestyle and Nutrition:
    Research examining the role of dietary factors and lifestyle changes in cardiovascular health is gaining prominence, indicating a broader understanding of prevention strategies beyond pharmacotherapy.
  3. Telemedicine and Remote Monitoring:
    Emerging themes related to the use of telemedicine and digital health technologies for cardiovascular disease management have gained attention, particularly in light of the COVID-19 pandemic, suggesting a shift towards more accessible healthcare models.
  4. Long-Term Outcomes and Quality of Care:
    There is a growing emphasis on the long-term outcomes of treatments and interventions in cardiovascular care, with studies increasingly focusing on quality of life and patient-centered metrics.

Declining or Waning

While the journal has a broad focus, certain themes that were once prominent appear to be declining in frequency or importance based on recent publications. This may reflect shifts in research priorities or advancements in technology and treatment options.
  1. Traditional Risk Factors:
    Research focusing solely on traditional cardiovascular risk factors such as hypertension and hyperlipidemia seems to be waning, as more recent studies emphasize broader and more holistic approaches to cardiovascular health.
  2. Invasive Diagnostic Procedures:
    There has been a noticeable decline in studies centered on invasive diagnostic techniques in favor of non-invasive imaging and biomarker identification, reflecting advancements in diagnostic technology.
  3. Acute Coronary Syndrome Management:
    While still relevant, specific studies exclusively addressing acute coronary syndrome management are less frequent, possibly due to a shift towards more comprehensive approaches that include long-term management and preventive strategies.

Similar Journals

Cardiology Research

Championing open access to vital cardiac research.
Publisher: ELMER PRESS INCISSN: 1923-2829Frequency: 6 issues/year

Cardiology Research is a prominent open-access journal dedicated to advancing the field of cardiology and cardiovascular medicine, published by ELMER PRESS INC. Renowned for its rigorous peer-review process, the journal provides a platform for cutting-edge research and innovative clinical practices in cardiology. With an ISSN of 1923-2829 and an E-ISSN of 1923-2837, it has established an impactful presence in the academic community, achieving a 2023 Scopus quartile ranking of Q3 in its category, positioning it in the 41st percentile. The journal's scope encompasses various aspects of cardiology research, including but not limited to epidemiology, diagnostics, therapeutics, and cardiovascular interventions. Although it operates without open access in certain contexts, it provides flexible access options for readers, ensuring that its valuable insights are widely disseminated. Cardiology Research is an essential resource for researchers, healthcare professionals, and students who aspire to stay at the forefront of cardiovascular science, contributing significantly to the global discourse on heart health.

Journal of Veterinary Cardiology

Unveiling Innovations in Veterinary Heart Care
Publisher: ELSEVIERISSN: 1760-2734Frequency: 4 issues/year

Journal of Veterinary Cardiology is a leading scientific publication dedicated to the field of veterinary cardiology, published by ELSEVIER. With an ISSN of 1760-2734 and E-ISSN 1875-0834, this journal plays a crucial role in disseminating cutting-edge research and clinical insights into animal cardiovascular health. With a strong emphasis on the interrelations of veterinary science and physiology, it boasts an impressive ranking in the Q1 category for miscellaneous veterinary studies and a significant position at 69th percentile in general veterinary rankings according to Scopus. Researchers, professionals, and students are encouraged to engage with the journal's diverse array of articles that span basic research to clinical applications, bridging knowledge gaps in veterinary cardiology. This important resource showcases impactful studies from its inception in 1999 and remains a steadfast conduit for the advancement of knowledge in the field through 2024 and beyond.

Cardiovascular Therapeutics

Pioneering Insights for a Healthier Heart
Publisher: WILEY-HINDAWIISSN: 1755-5914Frequency: 1 issue/year

Cardiovascular Therapeutics is a renowned Open Access journal, published by WILEY-HINDAWI, that has been at the forefront of advancing knowledge in the field of cardiology and cardiovascular medicine since its establishment. With a strong commitment to disseminating high-quality research, the journal has successfully positioned itself within the Q2 quartile in multiple categories, including Cardiology and Cardiovascular Medicine, Medicine (miscellaneous), and Pharmacology. The journal is indexed in Scopus, achieving impressive rankings, such as #95 out of 387 in Cardiology, and #87 out of 272 in Medical Pharmacology. Situated in the United Kingdom, Cardiovascular Therapeutics embraces an Open Access model since 2019, ensuring that groundbreaking research is accessible to researchers, practitioners, and students across the globe. The journal is dedicated to publishing original research articles, reviews, and clinical studies that contribute to the understanding and treatment of cardiovascular diseases, making it an essential resource for those invested in improving patient outcomes and advancing therapeutic strategies in this vital area of medicine.

Revista Portuguesa de Cardiologia

Empowering the fight against heart disease through open access research.
Publisher: ELSEVIER ESPANA SLUISSN: 0870-2551Frequency: 12 issues/year

Revista Portuguesa de Cardiologia, published by Elsevier España SLU, stands as a pivotal resource in the realm of Cardiology and Cardiovascular Medicine. With its origins tracing back to 1970, this journal has cultivated a robust academic presence, achieving a 2023 Q3 ranking in its category, and currently holding a position of #220 out of 387 on the Scopus rankings, placing it within the 43rd percentile of its field. This open access journal, available since 2011, aims to disseminate high-quality research and insights relevant to contemporary cardiovascular issues. Its commitment to accessibility and knowledge exchange enhances its importance for clinicians, researchers, and students alike, fostering a more informed community in the fight against cardiovascular diseases. Operating from its base in Barcelona, Spain, the journal welcomes contributions that further the understanding and treatment of heart conditions, contributing significantly to the advancement of cardiovascular health.

Korean Circulation Journal

Exploring the Frontiers of Cardiac Research and Innovation.
Publisher: KOREAN SOC CARDIOLOGYISSN: 1738-5520Frequency: 12 issues/year

Korean Circulation Journal, published by the Korean Society of Cardiology, has established itself as a prominent platform for disseminating research in the fields of Cardiology and Cardiovascular Medicine. With an ISSN of 1738-5520 and an E-ISSN of 1738-5555, this journal has been at the forefront of cardiovascular science since its inception in 2006 and is projected to continue until 2024. The journal's commitment to quality is reflected in its 2023 category quartiles, ranking in the second quartile (Q2) for both Cardiology and Internal Medicine, as well as its commendable Scopus rankings within the respective fields. Located in South Korea, the journal aims to bridge the gap between cutting-edge research and practical applications, serving as an invaluable resource for researchers, healthcare professionals, and students keen on advancing their understanding of cardiovascular health. Although currently not an open-access journal, it provides a wealth of knowledge that encourages evidence-based practice in clinical settings.

Postepy w Kardiologii Interwencyjnej

Empowering healthcare professionals with cutting-edge cardiology research.
Publisher: TERMEDIA PUBLISHING HOUSE LTDISSN: 1734-9338Frequency: 4 issues/year

Postepy w Kardiologii Interwencyjnej is a prominent scholarly journal dedicated to the field of interventional cardiology, published by the esteemed TERMEDIA PUBLISHING HOUSE LTD. Since its transition to an Open Access model in 2005, this journal has provided a platform for the dissemination of valuable research and clinical insights, reaching a broad audience of researchers, healthcare professionals, and students in Poland and beyond. With an ISSN of 1734-9338 and E-ISSN of 1897-4295, the journal has established its relevance by featuring articles that are currently indexed in Scopus, reflecting its impact in the field, particularly with a rank of #269 out of 387 in the category of Cardiology and Cardiovascular Medicine for 2023. The publication has continuously evolved to meet the demands of the scientific community, making it an essential resource for staying informed about the latest advancements in interventional techniques and cardiology research. With its commitment to enhancing the knowledge base of cardiovascular medicine, Postepy w Kardiologii Interwencyjnej plays a critical role in fostering collaboration and innovation within this vital specialty.

International Journal of Cardiology

Empowering Cardiology Research to Transform Patient Care
Publisher: ELSEVIER IRELAND LTDISSN: 0167-5273Frequency: 24 issues/year

The International Journal of Cardiology is a premier publication in the field of Cardiology and Cardiovascular Medicine, published by Elsevier Ireland Ltd. With an impressive impact factor and ranked in the top quartile (Q1) of its category, this journal serves as a vital resource for researchers, clinicians, and scholars committed to advancing cardiovascular health. Founded in 1981, the journal has been pivotal in disseminating significant findings, with a wide-ranging scope that includes original research, reviews, and clinical studies aimed at improving patient outcomes and understanding heart diseases. Its robust ranking of #73 out of 387 in Scopus ensures that it remains a leading platform for impactful cardiovascular research. While currently not an open-access publication, the journal's commitment to quality and relevance makes it an essential reference point within an ever-evolving medical landscape. For those engaged in cardiovascular research, the International Journal of Cardiology is not just a journal; it's an indispensable source of knowledge shaping the future of heart health.

Journal of the American Heart Association

Leading the Charge in Cardiovascular Knowledge and Care
Publisher: WILEYISSN: Frequency: 24 issues/year

The Journal of the American Heart Association, published by WILEY, serves as a premier platform for advancing cardiovascular medicine through its commitment to open access, fostering global dissemination of cutting-edge research since 2012. It proudly holds a prestigious position within the top quartile (Q1) in the categories of Cardiology and Cardiovascular Medicine, as evidenced by its Scopus ranking of #49 out of 387 journals, placing it in the 87th percentile. With a focus on innovative studies and transformative findings, this journal is essential for cardiologists, researchers, and healthcare professionals seeking to stay at the forefront of cardiovascular knowledge. The journal aims to bridge the gap between basic science and clinical practice, presenting findings that shape the future of heart health treatment and prevention. As a resource for academic and clinical communities alike, the Journal of the American Heart Association is dedicated to enhancing the understanding and treatment of cardiovascular diseases globally.

PROGRESS IN CARDIOVASCULAR DISEASES

Empowering Cardiovascular Excellence Through Research
Publisher: W B SAUNDERS CO-ELSEVIER INCISSN: 0033-0620Frequency: 6 issues/year

PROGRESS IN CARDIOVASCULAR DISEASES is a leading journal in the field of cardiology and cardiovascular medicine, published by W B SAUNDERS CO-ELSEVIER INC. With an impressive impact factor that places it in the esteemed Q1 quartile of its category, this journal ranks among the top 32 out of 387 journals in its field, positioning itself in the 91st percentile. Since its inception in 1958 and continuing until 2024, it has been a prolific source of cutting-edge research, reviews, and clinical insights that contribute significantly to the understanding and treatment of cardiovascular diseases. Although it does not currently offer open access options, the journal's rigorous peer-review process ensures that all published content meets the highest standards of scientific excellence. As a key resource for researchers, practitioners, and students alike, PROGRESS IN CARDIOVASCULAR DISEASES serves as an indispensable tool for advancing knowledge and practice in cardiovascular health.

Anatolian Journal of Cardiology

Fostering Cardiovascular Excellence Since 2001.
Publisher: KARE PUBLISSN: 2149-2263Frequency: 12 issues/year

The Anatolian Journal of Cardiology, published by KARE PUBL, stands as a vital resource in the field of Cardiology and Cardiovascular Medicine. With an ISSN of 2149-2263 and E-ISSN 2149-2271, this Open Access journal has been fostering the dissemination of critical research since 2001, ensuring that high-quality content is freely available to a global audience. Based in Turkey, the journal aims to bridge gaps in cardiological knowledge through rigorous peer-reviewed articles that span a wide range of topics, from innovative clinical practices to groundbreaking research findings. While its current ranking places it in the Q3 category of cardiology journals, the Anatolian Journal of Cardiology continues to strive towards enhancing its impact, currently holding a Scopus rank of 236 out of 387. Researchers, practitioners, and students alike will find this journal an essential platform for keeping abreast of the latest developments in cardiovascular health.